PEPID Bridges Disease and Treatment Data, Responds to Industry Demands
Enhanced CDS allows EHR systems to identify harmful medications, offer safer alternatives
Phoenix, AZ — January 29, 2013 —PEPID has announced it is the first data provider to allow healthcare professionals to search for appropriate medications based on a patient’s diagnosis, and give alerts if it’s a hazardous treatment based on any of the patient’s conditions, procedures or diagnostics tests. This information can be integrated into any EMR or HIT system, and can help prevent potentially harmful treatment options, and provide safer alternatives.
With the increase in drugs and complex treatment plans, today’s healthcare professionals rely on clinical decision support tools for treatment information and to alert them if a hazardous combination exists. PEPID, recognized world-wide as a leading provider of developer drug data and clinical decision support resources, recently added drug-indication and drug-contraindication coding to its robust clinical decision support resources.
“As more demands are placed on healthcare professionals, and with more patients on multi-drug therapies, having access to robust medication information in one place is essential,” says John Wagner, PEPID president. “There was a need for this in the industry that was not being met – we wanted to better serve our customers by providing the clinical decision support needed to identify potentially harmful treatment options, modify treatment and easily identify alternatives without interrupting their workflow.”
This addition includes drug to disease checkers that alerts providers when a prescribed medication should not be used, due to an underlying disease, recent procedures or diagnostic test, or condition, such as pregnancy. This module also easily allows systems to link treatments to the conditions they treat, in order to identify safe, or cost-effective alternatives.
“We’re providing clinicians with the capability to allow systems to check against the patient history and alert the healthcare practitioner if a potentially hazardous combination exists,” says Edward Reynolds, PEPID chief technology officer. “We’ve also incorporated the latest healthcare terminology, including ICD-10.”
PEPID contains the most extensive drug database on the market today, along with thousands of disease profiles and medical conditions, medical and dosing calculators, drug interactions checker, illustrations, laboratory values and differential diagnosis generator. All PEPID’s clinical decision support data and tools can be integrated into any healthcare information system, EMR, EHR or EDIS to help meet requirements for meaningful use.
PEPID’s reputable clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care, and this latest module adds to the robust content and tools available, and helps to meet meaningful use criteria in electronic medical records (EMR) systems.
Those attending HIMSS March 3-7, 2013 in New Orleans are encouraged to stop by PEPID’s booth #4837 to see a demonstration.
Learn more at pepid.com/indications-contraindications/
# # #
Contact: Jenna Reynolds
Phone: (888) 321-7828 x211
Email: press@pepid.com
About PEPID LLC
PEPID utilizes cutting-edge technology to deliver clinical decision-support resources specific for healthcare professionals including pharmacists, doctors, nurses, EMTs and students.
PEPID content is reviewed and contributed to by partners including the American Academy of Emergency Medicine, the National Association of Emergency Medical Services Educators, the Family Physician Inquiries Network, the National Association of Clinical Nurse Specialists, the Oncology Nursing Society, and the American Society of Health-System Pharmacists to ensure content is of the highest quality. Learn more at www.pepid.com, follow us on Twitter (@PEPID_LLC), or become a PEPID fan on Facebook.
Tags:
